Hengst Jeremy A, Guilford Jacquelyn M, Fox Todd E, Wang Xujun, Conroy Elizabeth J, Yun Jong K
Department of Pharmacology, The Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Arch Biochem Biophys. 2009 Dec;492(1-2):62-73. doi: 10.1016/j.abb.2009.09.013. Epub 2009 Sep 24.
Several studies have demonstrated that sphingosine kinase 1 (SphK1) translocates to the plasma membrane (PM) upon its activation and further suggested the plasma membrane lipid raft microdomain (PMLRM) as a target for SphK1 relocalization. To date, however, direct evidence of SphK1 localization to the PMLRM has been lacking. In this report, using multiple biochemical and subcellular fractionation techniques we demonstrate that endogenous SphK1 protein and its substrate, D-erythro-sphingosine, are present within the PMLRM. Additionally, we demonstrate that the PMA stimulation of SphK1 localized to the PMLRM results in production of sphingosine-1-phosphate as well as induction of cell growth under serum deprivation conditions. We further report that Ser225Ala and Thr54Cys mutations, reported to abrogate phosphatidylserine binding, block SphK1 targeting to the PMLRM and SphK1 induced cell growth. Together these findings provide direct evidence that the PMLRM is the major site of action for SphK1 to overcome serum-deprived cell growth inhibition.
多项研究表明,鞘氨醇激酶1(SphK1)在激活后会转位至质膜(PM),并进一步提示质膜脂筏微区(PMLRM)是SphK1重新定位的靶点。然而,迄今为止,缺乏SphK1定位于PMLRM的直接证据。在本报告中,我们使用多种生化和亚细胞分级分离技术证明,内源性SphK1蛋白及其底物D-赤藓糖鞘氨醇存在于PMLRM中。此外,我们证明,对定位于PMLRM的SphK1进行佛波酯(PMA)刺激会导致鞘氨醇-1-磷酸的产生以及在血清剥夺条件下诱导细胞生长。我们进一步报告称,据报道可消除磷脂酰丝氨酸结合的Ser225Ala和Thr54Cys突变会阻断SphK1靶向PMLRM以及SphK1诱导的细胞生长。这些发现共同提供了直接证据,表明PMLRM是SphK1克服血清剥夺诱导的细胞生长抑制作用的主要作用位点。